DUBLIN, Nov 09, 2016 /PRNewswire/ -- Research and Markets has announced the addition of the "Irritable Bowel Syndrome Drugs Price Analysis and Strategies - 2016" report to their offering.
Irritable Bowel Syndrome Drugs Price Analysis and Strategies 2016, provides drug pricing data and benchmarks in the global Irritable Bowel Syndrome market. The research answers the following questions: What are the key drugs marketed for Irritable Bowel Syndrome and their clinical attributes? How are they positioned in the Global Irritable Bowel Syndrome market? What are the unit prices and annual treatment cost for Irritable Bowel Syndrome therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries? What are the unmet needs in the global Irritable Bowel Syndrome drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Irritable Bowel Syndrome? Research Scope: Treatment Options - Identify key drugs marketed and prescribed for Irritable Bowel Syndrome including trade name, molecule name, and company Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Irritable Bowel Syndrome Market Positioning - Identify how drugs are clinically and commercially positioned in the global Irritable Bowel Syndrome market Irritable Bowel Syndrome Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed Find out how the price advanced from 2012 and forecast to 2021 Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape Irritable Bowel Syndrome New Drug Pricing - Identify the effective pricing strategy for a new drug launch